Comprehensive mutation analysis of TSC1 and TSC2 - And phenotypic correlations in 150 families with tuberous sclerosis

American Journal of Human Genetics

Volumn 64, Issue 5, 1999, Pages 1305-1315

  Jones, Alistair C ^a   Shyamsundar, Magitha M ^a   Thomas, Meinir W ^a   Maynard, Julie ^a   Idziaszczyk, Shelley ^a   Tomkins, Susan ^a   Sampson, Julian R ^a,b   Cheadle, Jeremy P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NUCLEOTIDE;

ALLELE; ARTICLE; DNA SEQUENCE; GENE MUTATION; HETERODUPLEX ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE;

EID: 0033365408     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302381     Document Type: Article

References (47)

1. Ad Hoc Committee on Mutation Nomenclature (1996) Update on nomenclature for human gene mutations. Hum Mutat 8:197-202
2. Ali JBM, Sepp T, Ward S, Green AJ, Yates JRW (1998) Mutations in the TSC1 gene account for a minority of patients with tuberous sclerosis. J Med Genet 35:969-972
3. Altschuler DL, Ribeiro Neto F (1998) Mitogenic and oncogenic properties of the small G protein rap1b. Proc Natl Acad Sci USA 95:7475-7479
4. Au K-S, Rodriguez JA, Finch JL, Volcik KA, Roach ES, Delgado MR, Rodriguez E Jr, et al (1998) Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients. Am J Hum Genet 62:286-294
5. Beauchamp RL, Banwell A, McNamara P, Jacobsen M, Higgins E, Northrup H, Short P, et al (1998) Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis. Hum Mutat 12:408-416
6. Brook-Carter P, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar M, Nellist M, et al (1994) Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat Genet 8: 328-332
7. Cooper DN, Krawczak M (eds) (1993) Human gene mutation. Bios Scientific Publishers, Oxford
8. European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterisation of the tuberous sclerosis gene on chromosome 16. Cell 75:1305-1315
9. Fleury P, de Groot WP, Delleman JW, Verbeeten B, Frankenmolen-Witkiezwicz IM (1980) Tuberous sclerosis: the incidence of familial versus sporadic cases. Brain Dev 2:107-117
10. Gomez MR (ed) (1988) Tuberous sclerosis, 2d ed. Raven Press, New York
11. Gorvel JP, Chavrier P, Zerial M, Gruenberg J (1991) Rab5 controls early endosome fusion in vitro. Cell 64:915-925
12. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, et al (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59:400-406
13. Jobert S, Bragado-Nilsson E, Samolyk D, Pedespan JM, Marchal C, Reichert S, Mallet J, et al (1997) Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein. Eur J Hum Genet 5:280-287
14. Jones AC, Daniells CE, Snell RG, Tachataki M, Idziaszczk SA, Krawczak M, Sampson JR, et al (1997) Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet 6:2155-2161
15. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823
16. Kobayashi T, Mitani H, Takahashi RI, Hirabayashi M, Ueda M, Tamura H, Hino O (1997) Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild type TSC2 transgene. Proc Natl Acad Sci USA 94:3990-3993
17. Kumar A, Kandt RS, Wolpert C, Roses AD, Pericak-Vance MA, Gilbert JR (1995a) Mutation analysis of the TSC2 gene in an African-American family. Hum Mol Genet 4: 2295-2298
18. Kumar A, Kandt RS, Wolpert C, Roses AD, Pericak-Vance MA, Gilbert JR (1997) A novel splice site mutation (156+1G-→A) in the TSC2 gene. Hum Mutat 9:64-65
19. Kumar A, Wolpert C, Kandt RS, Segal J, Pufky J, Rosed AD,Pericak-Vance MA, et al (1995b) A de novo frame-shift mutation in the tuberin gene. Hum Mol Genet 4:1471-1472
20. Kwiatkowska J, Jozwiak S, Hall F, Henske EP, Haines JL, McNamara P, Brasier J, et al (1998) Comprehensive mutational analysis of the TSC1 gene: observations on frequency of mutation, associated features and non-penetrance. Ann Hum Genet 62:277-285
21. Longa L, Scolari F, Brusco A, Carbonara C, Polidoro S, Valzorio B, Riegler P, et al (1997) A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 12:1900-1907
22. Maheshwar MM, Cheadle JP, Jones AC, Myring J, Fryer AE, Harris PC, Sampson JR (1997) The GAP related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Hum Mol Genet 6: 1991-1997
23. Maheshwar MM, Sandford R, Nellist M, Cheadle JP, Sgotto B, Vaudin M, Sampson JR (1996) Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. Hum Mol Genet 5:131-137
24. Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125-127
25. Plank TL, Yeung RS, Henske EP (1998) Hamartin, the product of the tuberous sclerosis (TSC1) gene, interacts with tuberin and appears to be localised to cytoplasmic vesicles. Cancer Res 58:4766-4770
26. Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, et al (1994) Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 58: 107-127
27. Roach ES, Gomez MR, Northrup H (1998) Tuberous sclerosis consensus conference: revised clinical diagnostic criteria. J Child Neurol 13:624-628
28. Sampson JR, Janssen LAJ, Sandkuijl LA, Tuberous Sclerosis Collaborative Group (1992) Linkage investigation of three putative tuberous sclerosis determining loci on chromosomes 9q, 11q and 12q. J Med Genet 29:861-866
29. Sampson JR, Maheshwar MM, Aspinwall R Thompson P, Cheadle JP, Ravine D, Roy S, et al (1997) Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 61:843-851
30. Sampson JR, Scahill SJ, Stephenson JBP, Mann L, Connor JM (1989). Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet 26:28-31
31. Sepp T, Green AJ, Yates JRW (1996) Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 33:962-964
32. Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP (1998) Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 62:810-815
33. Soucek T, Holzl G, Bernaschek G, Hengstschlager M (1998) A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 16:2197-2204
34. Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M (1997) Role of the tuberous sclerosis-2 gene product in cell cycle control. J Biol Chem 272:29301-29308
35. van Bakel I, Sepp T, Ward S, Yates JRW, Green AJ (1997) Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum Mol Genet 6:1409-1414
36. van den Ouweland AMW, Tempelaars A, Ariyurek Y, Wang Q, Hermans CJ, Nellist M, Bakker PLG, et al (1997) Identification of a mutational hotspot in the TSC2 gene. Am J Hum Genet Suppl 61:A349
37. van Slegtenhorst M, deHoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805-808
38. van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, et al (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053-1057
39. van Slegtenhorst M, Verhoef S, Tempelaars A, Bakker L, Wang Q, Wessels M, Bakker R, et al. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for a genotype-phenotype correlation. J Med Genet (in press)
40. Verhoef S, Vrtel R, Bakker L, Stolte Dijkstra I, Nellist M, Begeer JH, Zaremba J, et al (1998) Recurrent mutation 4882delTT in the GAP-related domain of the tuberous sclerosis TSC2 gene. Hum Mutat Suppl 1:S85-S87
41. Vrtel R, Verhoef S, Bouman K, Maheshwar MM, Nellist M, van Essen AJ, Bakker PLG, et al (1996) Identification of a nonsense mutation at the 5′ end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis. J Med Genet 33:47-51
42. Wang Q, Verhoef S, Tempelaars AMP, Bakker PLG, Vrtel R, Hesseling-Janssen ALW, Nellist M, et al (1998) Identification of a large insertion and two novel point mutations (3671de18 and S1221X) in tuberous sclerosis complex (TSC) patients. Hum Mutat 11:331-332
43. Wienecke R, Konig A, DeClue JE (1995) Identification of tuberin, the tuberous sclerosis-2 product-tuberin possesses specific rap1GAP activity. J Biol Chem 270:16409-16414
44. Wilson PJ, Ramesh V, Kristiansen, Bove C, Jozwiak S, Kwiatkowski DJ, Short MP, et al (1996) Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. Hum Mol Genet 5:249-256
45. Xiao G-H, Shoarinejad F, Jin F, Golemis EA, Yeung RS (1997) The tuberous sclerosis 2 gene product functions as a rab5a GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 272:6097-6100
46. York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJS (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392: 622-626
47. Young JM, Burley MW, Jeremiah SJ, Jeganathan R, Ekong R, Osborne JP, Povey S (1998) A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients. Ann Hum Genet 62:203-215